Yuyu Pharma (000220) — Cash Flow Reinvestment Rate
Yuyu Pharma (000220) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting ₩1.48 Billion (capex ₩1.46 Billion plus investments ₩-22.80 Million) from operating cash flow of ₩836.62 Million. Check earnings quality score of Yuyu Pharma to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yuyu Pharma Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Yuyu Pharma across 10 annual periods. Explore 000220 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Yuyu Pharma (2011–2024)
Year-by-year capital reinvestment analysis for Yuyu Pharma. For live market cap and broader valuation context, see Yuyu Pharma stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | ₩9.30 Billion | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.9% |
| 2023 | 17.93x | ₩7.55 Billion | ₩420.86 Million | ₩5.11 Billion | ▲ +1205.4% |
| 2021 | 1.37x | ₩6.19 Billion | ₩4.51 Billion | ₩6.07 Billion | ▲ +108.6% |
| 2019 | 0.66x | ₩8.68 Billion | ₩13.19 Billion | ₩8.06 Billion | ▼ -59.2% |
| 2018 | 1.61x | ₩9.87 Billion | ₩6.11 Billion | ₩9.76 Billion | ▼ -83.4% |
| 2017 | 9.74x | ₩5.46 Billion | ₩561.35 Million | ₩5.19 Billion | ▲ +2433.5% |
| 2016 | 0.38x | ₩3.77 Billion | ₩9.82 Billion | ₩2.32 Billion | ▼ -80.8% |
| 2014 | 2.00x | ₩2.73 Billion | ₩1.36 Billion | ₩404.37 Million | ▲ +1519.0% |
| 2012 | 0.12x | ₩805.15 Million | ₩6.51 Billion | ₩805.15 Million | ▲ +102.1% |
| 2011 | 0.06x | ₩408.49 Million | ₩6.67 Billion | ₩408.49 Million | — |